Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 October 2018
Dr Annamarie van Jaarsveld believes occupational therapy is important
Dr Annamarie van Jaarsveld believes occupational therapy is important for personal well-being.

On 27 October the profession of occupational therapy is promoted and celebrated internationally. The theme for this year is “Celebrating our global community.” Due to the theme of this year occupational therapists form all over the globe will be able to join in the World Federation for Occupational Therapy Virtual Exchange webinars.
 
Occupational therapy promotes health and well-being through occupation. The overarching goal of occupational therapy is to enable people to participate in the activities of everyday life that is meaningful to them. Occupational therapists work with people and communities in an effort to enable people of all ages to live life to its fullest by helping them maintain and/or promote health, and prevent (or live better with) injury, illness, or disability. 

Common occupational therapy interventions include helping children with disabilities to participate fully in school and social situations, helping people recovering from injury to regain skills, and providing supports for older adults experiencing physical and cognitive changes. Occupational and social justice along with occupational deprivation are core within the profession as it relates to oppression or restrictions to participation in occupation impacting on well-being and quality of life. 

Taking the lead in Sensory Integration research

Dr Annamarie van Jaarsveld is a lecturer in the Department of Occupational Therapy, and she is at the forefront of research in sensory integration, a specialist field within occupational therapy. Apart from completing her PhD on the curriculum design of a South African professional master’s degree qualification in sensory integration, she is also heading the South African leg of a large international study in collaboration with sensory integration experts all over the world.

Dr Van Jaarsveld explains: “The Evaluation of Ayres Sensory Integration (EASI) is a new test which aims to be a first of its kind in the field of sensory integration and occupational therapy. It will be inexpensive, electronically accessible and practical, and standardised on an international population which includes a South African sample. This will make the test accessible and useful for therapists in South Africa to be able to assess sensory integration related function of all South African children in a valid and reliable manner.” 

In addition to being the South African lead on the international EASI standardisation study, Annamarie was selected as the chairperson of the Board of Council Meetings of the International Council for Education in Ayres Sensory Integration (ICEASI). She is also the International Liaison on the board of the South African Institute for Sensory Integration. 

Annamarie’s passion for sensory integration and the application of a highly researched and specialised subfield where the expertise and guidance are provided by a first-world country is not only evident in her research, but also in various community projects that she is involved in. One such a project, Back to Urth Playgrounds, aims to make sensory integration relevant to the needs of South African children and their families struggling with sensory integration issues within the realities of diverse contexts. Through the designing of sustainable playgrounds based on sensory integration theory, building the playgrounds in collaboration with the community and other stakeholders, and equipping educators and caregivers with knowledge on how to encourage children to use the playgrounds, Annamarie has contributed to making the potential of sensory integration-based intervention accessible to the most under-resourced of areas. 

With the 27th of October being International Occupational Therapy Day, Annamarie says: “Sensory integration is not only the best researched field within occupational therapy, providing more and more best practice evidence through rigorous research, it is also becoming more available to children and families from all walks of life – indeed exciting times ahead for this field of practice and it remains a privilege to be involved in it”.  

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept